A vial of the Pfizer/BioNTech COVID-19 vaccine is seen forward of being administered on the Royal Victoria Hospital in Belfast, Northern Eire December 8, 2020.
Liam McBurney | Pool | Reuters
The U.S. Meals and Drug Administration is “quickly” working towards clearing Pfizer’s Covid-19 vaccine for emergency use after a key panel overwhelmingly endorsed the pictures Thursday night, Commissioner Stephen Hahn mentioned in a press release on Friday.
“Following yesterday’s constructive advisory committee assembly end result concerning the Pfizer-BioNTech COVID-19 vaccine, the U.S. Meals and Drug Administration has knowledgeable the sponsor that it’s going to quickly work towards finalization and issuance of an emergency use authorization,” Hahn mentioned in a press release.
“The company has additionally notified the U.S. Facilities for Illness Management and Prevention and Operation Warp Pace, to allow them to execute their plans for well timed vaccine distribution,” he mentioned.
Hahn’s feedback come the FDA’s Vaccines and Associated Organic Merchandise Advisory Committee on Thursday voted 17 to 4 with one abstention to to suggest the vaccine, which the corporate developed alongside BioNTech, for emergency authorization.
It is a growing story. Please examine again later for updates.